Correlation Between Maternal Weight Gain in Each Trimester and Fetal Growth According to Pre-pregnancy Maternal Body Mass Index in Twin Pregnancies

doi:10.21203/rs.3.rs-1022930/v1

Download PDF

Research Article

Correlation Between Maternal Weight Gain in Each Trimester and Fetal Growth According to Pre-pregnancy Maternal Body Mass Index in Twin Pregnancies

https://doi.org/10.21203/rs.3.rs-1022930/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Background: This study aimed to determine the correlation between maternal weight gain in each trimester and fetal growth according to pre-pregnancy maternal body mass index in twin pregnancies.

Methods: We conducted a retrospective review of the medical records of 500 twin pregnancies delivered at 28 weeks’ gestation or greater at a single tertiary center between January 2011 and December 2020. We measured the height, pre-pregnant body weight, and maternal body weight of women with twin pregnancies and evaluated the relationship between the maternal weight gain at each trimester and fetal growth restriction according to pre-pregnancy body mass index.

Results: The overweight pregnant women were older than the normal or underweight pregnant women, and the risk of gestational diabetes was high. The underweight pregnant women were younger, and the incidences of preterm labor and short cervical length during pregnancy was high. Especially in normal weight pregnant women, the heavier the weight of the newborn babies as the second trimester of pregnancy weight gain, the less significant the weight gain in the first trimester of pregnancy and fetal growth. The most predictive single factor for the prediction of small neonates was weight gain during 24-28 weeks and 15-18 weeks, and the cutoff value was 6.2 kg. (area under the curve 0.592, p < 0.001).

Conclusions: In twin pregnancy, regardless of the pre-pregnant body mass index, maternal weight gain affected fetal growth. Furthermore, weight gain in the second trimester of pregnancy is considered a powerful indicator of fetal growth, especially in normal weight pregnancies.

Maternal & Fetal Medicine

twin pregnancy

maternal weight gain

fetal growth

maternal complications

neonatal outcomes

Twin pregnancies account for about 1%-3% of all pregnancies. The incidence of twin pregnancies has been increasing due to advanced maternal age and the development of assisted reproductive techniques (ARTs) (1, 2). Twin pregnancies involve complications, including twin-specific problems. Compared with singleton pregnancy, twin pregnancy not only increases the possibilities of obstetric complications, such as preterm labor, preeclampsia, gestational diabetes, and operative delivery (3, 4), but also includes many neonatal problems, such as miscarriage, fetal death in utero, preterm birth, and fetal growth restriction (5-7). Many attempts thus far have been made to improve the obstetric or neonatal prognosis in twin pregnancy.

In singleton pregnancy, some studies have shown that proper weight gain during pregnancy is associated with obstetric prognosis. Many researchers have suggested criteria for appropriate weight gain during pregnancy based on the maternal pre-pregnancy weight (8, 9).

In twin pregnancy, proper maternal weight gain during pregnancy is associated with pregnancy-related complications and neonatal outcomes, as in singleton pregnancy (10-12). If the mother is tall, and the maternal weight gain during pregnancy is appropriate, maternal weight gain can predict fetal growth. The Institute of Medicine and the National Research Council in 1990 and 2009, respectively, presented criteria for adequate weight gain in twin pregnancy (3, 13). However, determining the correlation between maternal weight gain and gestational age of pregnancy was difficult, as it focused on the total weight gain during the entire pregnancy period. Moreover, unlike in singleton pregnancies, twin pregnancy mothers have a higher likelihood of weight gain and pregnancy-related complications, such as fetal growth restriction, preeclampsia, or gestational diabetes (3, 4). Furthermore, defining proper weight gain is difficult without considering race, socioeconomic status, maternal health, and maternal height. Twin pregnancy particularly often results in early delivery due to early labor. The twin pregnancy itself increases the risk of newborns who are small for gestational age (SGA). SGA can increase several morbidities, such as neonatal intensive care unit (NICU) admission, respiratory complications, and jaundice. Therefore, presenting appropriate weight gain values during pregnancy according to the trimester of pregnancy will help prevent and predict SGA.

This study sought to investigate the relationship between fetal growth and maternal weight gain according to the trimester of twin pregnancy. Based on the weight of the neonates, the patients were divided into two groups: (1) AGA (adequate for gestational age) group (AGA-AGA) and (2) SGA group (AGA-SGA or SGA-SGA). Maternal weight and weight gain were compared between the groups. In addition, the patients were divided into three groups according to pre-pregnant BMI (body mass index): underweight, normal, and overweight. The relationship between maternal weight gain and fetal growth was assessed in each group. We aimed to find out whether the amount of maternal weight gain during pregnancy could be a significant prognostic factor or SGA in twin pregnancy.

We conducted a retrospective medical record review of 500 Korean patients with twin pregnancies who delivered at 28 weeks’ gestation or greater at a single center (Chilgok Kyungpook National University Hospital) in Daegu, South Korea, between January 2011 and December 2020. Forty-two women were excluded because of major fetal anomalies, chromosomal abnormalities, and fetal death in utero. Four women with monochorionic-monoamniotic twins were also excluded. When the chorionicity in the medical records and placental pathologic findings after delivery differed, the pathologic results were followed. Twelve cases of twin-to-twin transfusion syndromes were also excluded. Overall, 79 pregnancies were excluded based on the exclusion criteria, and 442 twin pregnancies were reviewed. Maternal height, pre-pregnant body weight, and body weight were measured. Of these, we analyzed the maternal body weights between 15 and 18 weeks of gestation, 20 and 24 weeks of gestation, and 24 and 28 weeks of gestation, as well as weight at delivery. We also evaluated the differences in maternal body weight at each period and determined the weight gain during pregnancy. Ninety-nine pregnancies that did not have weight measurement data at each period were excluded. Thus, the final number of pregnancies included in the analyses was 343.

BMI was measured using maternal height and weight before pregnancy. The groups with BMI values of less than 18.5 were classified as underweight, the groups with BMI values of 25 or higher were classified as overweight, and the groups with BMI values between 18.5 and 25 were classified as normal weight. The obstetric and neonatal outcomes of each group were compared.

Maternal characteristics, such as age at delivery, height, parity, the use of ARTs, chorionicity, and pregnancy-related complications, such as preeclampsia, placenta previa, overt diabetes, gestational diabetes (GDM), threatened preterm labor, short cervical length, premature membrane rupture (PROM), and postpartum bleeding, were compared. Preeclampsia was defined as having a blood pressure of 140/90 mmHg or more and proteinuria after 20 weeks of gestation in accordance with the criteria of the International Society for the Study of Hypertension in Pregnancy. For GDM, a 50-g glucose tolerance test was performed as screening between 24 and 28 weeks of gestation, and a 100-g glucose tolerance test was performed when the value was over 140 mg/dL. GDM was diagnosed in accordance with the Carpenter–Coustan criteria. Placenta previa was defined by evaluating the location of the placenta through ultrasound immediately before delivery. Threatened preterm labor was defined as inpatient conservative treatment before 37 weeks of gestation due to regular uterine contractions and a short cervical length of less than 2.5 cm. Postpartum bleeding was defined as massive bleeding of more than 1 liter or requiring transfusion due to anemia after delivery. Deliveries scheduled on a date were classified as elective, deliveries due to labor pain were classified as spontaneous, and emergency deliveries due to preeclampsia or poor fetal condition were classified as iatrogenic.

The neonatal outcomes, including sex, gestational age at delivery, neonatal birth weight, the rate of SGA, twin weight discordance, 1-minute Apgar score, 5-minute Apgar score, and NICU admission, were analyzed. Weight below the 10th percentile corrected for gestational age and sex was defined as SGA, and more than that was defined as AGA (14). Twin weight discordance was determined using neonatal birth weight multiplied by 100 after dividing the difference between the weights of the two neonates by the weight of the large baby, as defined in previous studies. If the value obtained was more than 20%, the twins were classified as discordant twins, and if the value was less than 20%, the twins were classified as concordant (15). Each of the normal, underweight, and overweight groups were further divided based on the neonatal weights: AGA-AGA group and AGA-SGA or SGA-SGA group. Maternal weight and weight gain during pregnancy were also compared. This study was approved by the Institutional Review Board (IRB) of Chilgok Kyungpook National University Hospital (IRB No. KNUCH 2021-04-037). Informed consent was not obtained from the study participants due to the retrospective nature of the study in reviewing medical records.

Statistical Analyses

All data were analyzed using the SPSS software (version 26.0; SPSS Inc., Chicago, IL, USA) and R version 4.0.0 (Vienna, Austria; www.r-project.org/). The data on the AGA, AGA-SGA, and SGA-SGA groups were compared using the Mann–Whitney U test for continuous numerical data, whereas the χ² test was used for binary categorical data. Data were presented as mean ± standard deviation (SD) for continuous variables with normal distributions and number (percentage) for binary categorical data. A p-value <0.05 was considered statistically significant.

This study included 343 twin pregnancies and 686 neonates. The patients were divided into underweight, normal weight, and overweight, which comprised 9.6%, 71.1%, and 19.2% of the study population, respectively.

Table 1 compares the maternal characteristics and pregnancy-related complications according to pre-pregnant BMI. Compared with the normal weight group, underweight twin pregnancies were significantly younger, with a mean ± SD age at delivery of 30.24 ± 5.13 years (vs. 32.28 ± 4.13 years, p = 0.003), and significantly lower in weight, with a weight gain during pregnancy of 13.04 ± 5.35 kg (vs. 14.72 ± 7.13 kg, p = 0.024). However, no statistical significance could be found in parity, maternal height, the use of ARTs, and chorionicity. The incidence of preeclampsia in underweight pregnancies was 3.03%, which was significantly lower than that in the normal BMI with 13.11% (p = 0.030). However, the frequency of preterm labor was significantly higher in the underweight group (81.82% vs. 58.20%, p < 0.001). In the underweight group, emergency delivery due to reasons such as spontaneous labor or ROM was significantly higher than that in the normal weight group (60.61% vs. 45.68%, p = 0.035). In the overweight group, age at delivery was 33.44 ± 3.95 years old and was significantly higher than that in the normal weight group (p = 0.004). Weight gain during pregnancy in the overweight group was 11.53 ± 5.49 kg, which was significantly lower than that in the normal weight group (14.72 ± 7.13 kg, p < 0.001). No significant difference in the use of ART (54.55% vs. 55.14%, p = 0.880) was observed, but the frequency of dichorionic twins tended to be higher in the overweight group (84.85% vs. 75.82%, p = 0.036). In the overweight group, the frequencies of chronic hypertension (3.03% vs. 0.00%, p = 0.001) and GDM were higher (27.27% vs. 10.25%, p < 0.001), but the frequency of preeclampsia was lower compared with the normal weight group (6.06% vs. 13.11%, p = 0.037). The cause of delivery did not differ significantly between the overweight and normal weight groups.

Table 2 compares the neonatal outcomes according to pre-pregnant BMI. Delivery in the underweight group was earlier compared with the normal weight group (34.08 ± 2.90 weeks vs. 34.93 ± 2.89 weeks, p = 0.025) and neonatal birth weight was lower (1939.02 ± 228.46 g vs. 2193.02 ± 521.92 g, p < 0.001). But the incidence of SGA did not vary significantly between both groups (19.70% vs. 19.06%, p=1.000). In addition to twin weight discordance, neonatal outcomes, such as Apgar score at 1 and 5 minutes, NICU admission, the requirement for oxygen, and intubation, did not differ significantly. Neonatal birthweight percentile was higher in the overweight group compared with the normal weight group, (30.14 ± 21.23 vs. 36.61 ± 22.46, p = 0.002), but no significant difference was observed in gestational age at delivery, sex, neonatal birthweight, and incidence of SGA. Furthermore, no statistical difference was observed in the neonatal outcomes, such as discordancy, Apgar score at 1 and 5 minutes, NICU admission, the requirement for oxygen, and intubation.

Table 3 compares the obstetrical complications, neonatal prognosis, and maternal weight gain between the AGA-AGA group and AGA-SGA or SGA-SGA group, regardless of BMI based on maternal pre-pregnancy weight. In the AGA-SGA or SGA-SGA group, the maternal age was significantly higher (33.67 ± 3.97 years vs. 31.67 ± 4.27 years, p < 0.001), the pregnancies were significantly more nulliparous (76.15% vs. 65.38%, p = 0.001), and significantly more conceptions occurred through ART (65.14% vs. 48.93%, p < 0.001) compared with those in the AGA group. No significant difference was observed in the frequency of GDM, but the tendency of preeclampsia was significantly higher in the SGA group (16.51% vs. 8.12%, p = 0.002). Compared with the AGA-SGA or SGA-SGA group, the risk of threatened preterm labor significantly increased (69.23% vs. 41.28%, p < 0.001), the presence of short cervical lengths below 2.5 cm was significantly higher (53.85% vs. 29.47%, p < 0.001), and the rate of PROMs was also significantly higher (29.06% vs. 16.51%, p = 0.001) in the AGA-AGA group. In the SGA group had a higher frequency of spontaneous delivery than elective or iatrogenic ones (p < 0.001). Compared with the AGA-AGA group, the SGA-SGA or AGA-SGA group had a higher gestational age at delivery (35.81 ± 2.24 weeks vs. 34.37 ± 2.99 weeks, p < 0.001), a smaller birth weight (2117.34 ± 474.37 g vs. 2206.85 ± 558.34 g, p = 0.030), and a smaller placenta. The frequency of NICU hospitalization was higher in the SGA group (77.06% vs. 68.45%, p = 0.025), but no significant difference was observed in other neonatal outcomes in both groups. In the SGA group, the women were shorter than those in the AGA group (159.85 ± 4.72 cm vs. 161.40 ± 5.10 cm, p < 0.001), had a lower pre-pregnancy weight ( 55.83 ± 9.41 kg vs. 58.52 ± 11.07 kg, p = 0.001), and had a lower weight at delivery (69.65 ± 9.15 kg vs. 72.26 ± 12.30 kg, p = 0.002). Weight measurements at 15-18 weeks and 24-28 weeks of gestation were also lower in the SGA group.

Table 4 compares the maternal weight and weight gain according to gestational age between AGA-AGA and AGA-SGA or SGA-SGA in the normal weight group. In the SGA sub-group, the maternal height was lower (160.14 ± 4.25 cm vs. 161.32 ± 5.22 cm, p = 0.008), but no statistical difference was found between the two groups in pre-pregnancy weight and weight at delivery compared with the AGA group. However, the weight at 15-18 weeks (56.19 ± 5.64 kg vs. 58.42 ± 6.37 kg, p = 0.004) and 24-28 weeks of gestation (63.27 ± 5.23 kg vs. 65.54 ±6.93 kg, p = 0.003) tended to be lower. Comparison according to trimester showed the SGA group had a significantly smaller weight gain in the second trimester of pregnancy compared with the AGA group (6.50 ± 2.04 kg vs. 7.21 ± 2.87 kg, p = 00043). On the other hand, weight gain in the third trimester of pregnancy was higher in the SGA group (6.27 ± 2.96 kg vs. 5.00 ± 3.67 kg, p = 0.003).

Table 5 compares the maternal weight and weight gain according to gestational age between AGA-AGA and AGA-SGA or SGA-SGA in the overweight group. In the SGA group, gestational age at delivery was higher (35.52 ± 1.97 weeks vs. 34.54 ± 2.82 weeks, p = 0.032) and the maternal height was smaller (158.38 ± 6.25 cm vs. 160.97 ± 5.09 cm, p = 0.020) compared with the AGA group. No significant difference in pre-pregnancy weight was observed between the two groups. However, the weights at 15-18 weeks (75.84 ± 8.49 kg vs. 70.43 ± 5.79 kg, p = 0.001) and 24-28 weeks of gestation (82.85 ± 9.85 kg vs. 75.61 ± 6.07 kg, p = 0.001) and at delivery (86.42 ± 11.06 kg vs. 80.29 ± 11.77 kg, p = 0.008) were lower. Comparison according to trimester, showed no significant difference in weight gain between the SGA and AGA group.

Table 6 compares the maternal weight and weight gain according to gestational age between the AGA-AGA and AGA-SGA or SGA-SGA in the underweight group. The SGA group had a higher gestational age at delivery (35.11 ± 2.24 weeks vs. 33.49 ± 3.09 weeks, p = 0.028), and smaller maternal height (159.67 ± 5.30 cm vs. 162.48 ± 3.82 cm, p = 0.015) compared with the AGA group. No statistical difference was observed between the two groups in pre-pregnancy weight. The weight at 15-18 weeks of gestation was lower (46.78 ± 4.35 kg vs. 50.17 ± 4.03 kg, p = 0.022). However, no significant difference was observed in the weights at 20-24 weeks of gestation, at 24-28 weeks of gestation, and at delivery. Moreover, no significant difference was found in weight gain according to trimester between the AGA and SGA groups.

Figure 1 shows the area under the curve (AUC) of the predictive values for maternal weight and weight gain during pregnancy for SGA in twin pregnancy. The single predictive factor for SGA was weight gain during 24-28 weeks and 15-18 weeks, i.e., during the second trimester of pregnancy, and the cutoff value was 6.2 kg (AUC = 0.592, p < 0.001). The combined factors for the prediction of SGA in twin pregnancy were weight gain between 24-28 and 15-18 weeks and weight gain between 20-24 and 15-18 weeks, with an AUC of 0.585 at cutoff values of 6.8 kg and 4 kg, respectively (p < 0.001).

In this study, the patients in the overweight group were older, had smaller maternal weight gains during pregnancy, and had a higher risk of GDM than those in the normal or underweight group. However, no significant differences in the incidence of preterm labor or abnormal placentation were observed. In singleton pregnancy, maternal overweight or obesity is known to increase pregnancy-related complications (16, 17), but this needs to be investigated further in twins. Some studies reported that twin pregnancy, unlike singleton pregnancy, was not associated with pre-pregnancy overweight and GDM (18), but other studies have indicated that a higher BMI before pregnancy resulted in a higher rate of GDM (19). This finding is consistent with that of the present study.

In our study, the patient in the underweight group were younger at delivery than the normal or overweight group and had a smaller weight gain during pregnancy. Furthermore, the rate of preterm labor and short cervical length during pregnancy was high in the underweight group; thus, the possibility of emergency delivery was higher. According to Lilly et al., if weight gain by underweight mothers during pregnancy reached the recommended value for normal BMI mothers, the frequency of preterm labor and pregnancy-related complications did not increase (20). We found that underweight women had relatively smaller weight gains, which is a study of Asians who are relatively small compared to Westerners who have been mainly studied so far, so it is thought that there is a difference in these results.

Comparing the birthweight with weight percentile values corrected for gestational age at delivery and sex showed that the neonatal size was decreased in the order of overweight, normal weight, and underweight groups. However, no significant difference was observed in the incidence of SGA and in the short-term prognosis of neonates among the groups. However, this study confirmed that the probability of an SGA baby being born to an underweight woman is about 20%. This was significant lower compared with the 50%-60% reported in other studies (21), and may be due to the differences in socioeconomic status, nutritional support, and lifestyle, including smoking or alcohol.

In twin pregnancy, if at least one twin has a fetal growth restriction of less than 10%, the average maternal age and the incidence of preeclampsia tended to be higher, which may negatively affect fetal growth (22, 23). Interestingly, the AGA-AGA group had more cases of threatened preterm labor, short cervical length, and premature membrane rupture than the SGA group, all of which resulted in preterm birth. This may be because the heavier the fetus, the larger the placenta and the amount of amniotic fluid would be, resulting in the overextension of the uterus and subsequent early labor. However, no significant difference was observed in the short-term outcomes of newborns between the two groups except for NICU hospitalization. Furthermore, the taller the pregnant woman is, the heavier the maternal weight before pregnancy. On the other hand, the greater the weight gain by trimester of pregnancy, the more likely the neonate is AGA. This is consistent with the finding of another study indicating that when normal weight pregnant women achieve the recommended weight gain during pregnancy, prognosis related to several pregnancy complications, such as SGA and preterm birth, is better (24-26). Bodnar et al. reported that across all BMI groups, if the weight gain is too small or too much, the risk of infant death increases. Furthermore, weight gain and SGA are inversely proportional, whereas and LGA and cesarean delivery are inversely proportional (27).

In the present study, especially in the normal weight group, the closer the neonatal weight to the weight gain in the second trimester of pregnancy, the less significant the weight gain in the first trimester of pregnancy and fetal growth would be. On the other hand, the reason why the third trimester weight increase is higher in the SGA group is probably the relatively later delivery in the SGA group. Wen et al. reported that in dichorionic twins, weight gain in early pregnancy was found to be associated with birth weight (28). Lilly et al. reported that weight gain in the second and first trimesters of pregnancy is associated with fetal growth, whereas weight gain after 24 weeks is associated with preterm labor (20). However, the above studies are different from our research in that these were studies on normal weight twin pregnancies. In addition, the possibility of SGA in at least one of the two fetuses was higher when the weight increase in the second trimester of pregnancy was less than 6.2 kg in the Korean population. Thus, the possibility of SGA can be predicted using weight gain in the second trimester of pregnancy, which can help improve the prognosis.

The strength of this study is that the single center from which the data were obtained had consistently evaluated pregnant women, including only single ethnicity populations, measured the weight of all pregnancies in a series using the same machine from the beginning of pregnancy. Thus, a cutoff value was set to create an SGA prediction model. On the other hand, this study is limited by a small size, an unequal number of participants for each BMI group, and selection bias, considering only a single tertiary center was evaluated.

In twin pregnancy, regardless of pre-pregnant BMI, maternal weight gain affects fetal growth. Particularly, weight gain in the second trimester of pregnancy can be considered a powerful indicator for fetal growth, especially in normal weight pregnancies.

ART, assisted reproductive techniques; SGA, small for gestational age of newborn; NICU, neonatal intensive care unit; AGA, adequate for gestational age of newborn; BMI, body mass index; GDM, gestational diabetes; PROM, premature membrane rupture; AUC, area under the curve

All methods were carried out in accordance with relevant guidelines and regulations.

Ethics approval and consent to participate: This study was approved by the Institutional Review Board (IRB) of Chilgok Kyungpook National University Hospital (IRB No. KNUCH 2021-04-037). Informed consent form participants were waived due to the retrospective nature of the study and it was also approved by the IRB of Chilgok Kyungpook National University Hospital

Consent for publication: Not applicable

Availability of data and materials: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Competing interests: The authors declare that they have no conflict of interests.

Funding: This research was supported by Kyungpook National University Research Fund, 2021

Authors' contributions

Mi Ju Kim: study design, planning, data collection, data analysis, and manuscript writing/editing.

Hyun Mi Kim: data collection, data analysis, manuscript writing.

Hyun Hwa Cha: study design, data collection, planning.

Won Joon Seong: conduct, data analysis.

Acknowledgements: Not applicable

ACOG Practice Bulletin No. 144: Multifetal gestations: twin, triplet, and higher-order multifetal pregnancies. Obstet Gynecol. 2014;123:1118-32.
Park YH, Kim YN, Im DH, Kim DH, Byun JM, Jeong DH, et al. Neonatal outcomes between discordant monochorionic and dichorionic twins. J Matern Fetal Neonatal Med. 2019:1-9.
Luke B, Brown MB. Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality. Fertil Steril. 2007;88:283-93.
Sparks TN, Nakagawa S, Gonzalez JM. Hypertension in dichorionic twin gestations: how is birthweight affected? J Matern Fetal Neonatal Med. 2017;30:380-5.
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67:1-50.
MacDorman MF, Gregory EC. Fetal and perinatal mortality: United States, 2013. Natl Vital Stat Rep. 2015;64:1-24.
ACOG Practice Bulletin #56: Multiple gestation: complicated twin, triplet, and high-order multifetal pregnancy. Obstet Gynecol. 2004;104:869-83.
Pugh SJ, Albert PS, Kim S, Grobman W, Hinkle SN, Newman RB, et al. Patterns of gestational weight gain and birthweight outcomes in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singletons: a prospective study. Am J Obstet Gynecol. 2017;217:346.e1-.e11.
Sridhar SB, Xu F, Hedderson MM. Trimester-specific gestational weight gain and infant size for gestational age. PLoS One. 2016;11:e0159500.
Luke B, Gillespie B, Min SJ, Avni M, Witter FR, O'Sullivan MJ. Critical periods of maternal weight gain: effect on twin birth weight. Am J Obstet Gynecol. 1997;177:1055-62.
Lantz ME, Chez RA, Rodriguez A, Porter KB. Maternal weight gain patterns and birth weight outcome in twin gestation. Obstet Gynecol. 1996;87:551-6.
Luke B, Minogue J, Witter FR, Keith LG, Johnson TR. The ideal twin pregnancy: patterns of weight gain, discordancy, and length of gestation. Am J Obstet Gynecol. 1993;169:588-97.
Institute of M, National Research Council committee to reexamine IOMPWG. The National Academies Collection: reports funded by National Institutes of Health. In: Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: reexamining the guidelines. Washington (DC): National Academies Press (US) Copyright ©. National Academy of Sciences; 2009.
Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6.
Khalil A, Rodgers M, Baschat A, Bhide A, Gratacos E, Hecher K, et al. ISUOG practice guidelines: role of ultrasound in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47:247-63.
Alanis MC, Goodnight WH, Hill EG, Robinson CJ, Villers MS, Johnson DD. Maternal super-obesity (body mass index > or = 50) and adverse pregnancy outcomes. Acta Obstet Gynecol Scand. 2010;89:924-30.
Torloni MR, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194-203.
Liu LY, Zafman KB, Fox NS. Weight gain and pregnancy outcomes in overweight or obese women with twin gestations. J Matern Fetal Neonatal Med. 2021;34:1774-9.
Kim SY, Hong SY, Kim Y, Kwon DY, Park H, Sung JH, et al. Maternal pre-pregnancy body mass index and the risk for gestational diabetes mellitus in women with twin pregnancy in South Korea. Taiwan J Obstet Gynecol. 2021;60:863-8.
Liu LY, Zafman KB, Fox NS. The association between gestational weight gain in each trimester and pregnancy outcomes in twin pregnancies. Am J Perinatol. 2021;38:567-74.
Liu LY, Zafman KB, Fox NS. Weight gain and pregnancy outcomes in underweight women with twin gestations. J Matern Fetal Neonatal Med. 2020;33:2877-81.
Lucovnik M, Blickstein I, Verdenik I, Steblovnik L, Trojner Bregar A, Tul N. Impact of pre-gravid body mass index and body mass index change on preeclampsia and gestational diabetes in singleton and twin pregnancies. J Matern Fetal Neonatal Med. 2014;27:1901-4.
Fox NS, Saltzman DH, Kurtz H, Rebarber A. Excessive weight gain in term twin pregnancies: examining the 2009 Institute of Medicine definitions. Obstet Gynecol. 2011;118:1000-4.
González-Quintero VH, Kathiresan AS, Tudela FJ, Rhea D, Desch C, Istwan N. The association of gestational weight gain per institute of medicine guidelines and prepregnancy body mass index on outcomes of twin pregnancies. Am J Perinatol. 2012;29:435-40.
Shamshirsaz AA, Haeri S, Ravangard SF, Sangi-Haghpeykar H, Gandhi M, Ozhand A, Spiel M, Trout S, Sadowski A, Hussain N, Campbell WA, Shamshirsaz AA. Perinatal outcomes based on the institute of medicine guidelines for weight gain in twin pregnancies. J Matern Fetal Neonatal Med. 2014;27:552-6.
Ozcan T, Bacak SJ, Zozzaro-Smith P, Li D, Sagcan S, Seligman N, Glantz CJ. Assessing weight gain by the 2009 Institute of Medicine guidelines and perinatal outcomes in twin pregnancy. Matern Child Health J. 2017;21:509-15.
Bodnar LM, Himes KP, Abrams B, Lash TL, Parisi SM, Eckhardt CL, Braxter BJ, Minion S, Hutcheon JA. Gestational weight gain and adverse birth outcomes in twin pregnancies. Obstet Gynecol. 2019;134:1075-86.
Wen L, Liu X, Wang L, Zheng Y, Li J, Tong C, Qi H, Saffery R, Baker P. Correlation between second trimester weight gain and perinatal outcomes in dichorionic twin pregnancies: the LoTiS cohort study. Eur J Obstet Gynecol Reprod Biol. 2019;233:64-9.

Table 1. Maternal characteristics and pregnancy-related complications according to maternal prepregnant BMI in twin pregnancy

	Underweight (n = 33)	Normal weight (n = 244)	Overweight (n = 66)	p value	p-value α	p-value β	p-value ɤ
Maternal age (years)	30.24 ± 5.13	32.28 ± 4.13	33.44 ± 3.95	<0.001*	0.003*	<0.001*	0.004*
Nulliparous, n (%)	23 (69.70%)	172 (70.49%)	41 (62.12%)	0.018*	0.237	0.040*	0.022*
Height (cm)	161.45 ± 4.58	160.97 ± 4.95	160.43 ± 5.51	0.153	0.450	0.194	0.279
Weight gain during pregnancy (kg)	13.04 ± 5.35	14.72 ± 7.13	11.53 ± 5.49	0.006*	0.024*	0.068	<0.001*
ART, n (%)	15 (45.45%)	134 (55.14%)	36 (54.55%)	0.516	0.237	0.278	0.880
Monochorionic, n (%)	9 (27.27%)	59 (24.18%)	10 (15.15%)	0.059	0.692	0.064	0.036*
Dichorionic, n (%)	24 (72.73%)	185 (75.82%)	56 (84.85%)
Chronic HTN, n (%)	0 (0.00%)	0 (0.00%)	2 (3.03%)	<0.001*		0.372	0.001*
Preeclampsia, n (%)	1 (3.03%)	32 (13.11%)	4 (6.06%)	0.007*	0.030*	0.566	0.037*
Overt DM, n (%)	1 (3.03%)	0 (0.00%)	1 (1.52%)	0.003*	0.006*	0.858	0.063
Gestational DM, n (%)	3 (9.09%)	25 (10.25%)	18 (27.27%)	<0.001*	0.941	0.006*	<0.001*
Placenta previa, n (%)	2 (6.06%)	7 (2.87%)	1 (1.52%)	0.027*	0.014*	0.101	0.264
Threatened preterm, n (%)	27 (81.82%)	142 (58.20%)	38 (57.58%)	0.001*	<0.001*	0.001*	0.977
PROM, n (%)	10 (30.30%)	59 (24.18%)	17 (25.76%)	0.549	0.354	0.612	0.795
Short cervix, n (%)	17 (51.52%)	118 (48.36%)	26 (39.39%)	0.138	0.726	0.142	0.083
Cause of delivery, n (%) Elective Spontaneous Iatrogenic	7 (21.21%) 20 (60.61%) 6 (18.18%)	89 (36.63%) 111 (45.68%) 83 (17.70%)	26 (39.39%) 31 (46.97%) 9 (13.64%)	0.081	0.035*	0.038*	0.531

*p value < 0.05. Underweight, BMI < 18.5; normal, 18.5 < BMI < 25; overweight, BMI >25; p-value α, between underweight BMI and normal BMI; p-value β, between underweight BMI and overweight BMI; p-value ɤ, between normal BMI and overweight BMI; BMI, body mass index; ART, artificial reproductive technique; HTN, DM, diabetes mellitus; PROM, premature rupture of amniotic membrane.

Table 2. The neonatal outcomes according to maternal prepregnant BMI in twin pregnancy

	Underweight (n = 66)	Normal weight (n = 488)	Overweight (n = 132)	p-value e	p-value α	p-value β	p-value ɤ
Gestational age at Delivery, weeks	34.08 ± 2.90	34.93 ± 2.89	34.82 ± 2.66	0.220	0.025*	0.075	0.696
Sex (male), n (%)	30 (45.45%)	259 (53.07%)	62 (46.97%)	0.286	0.302	0.960	0.251
Birthweight (g)	1939.02 ± 228.46	2193.02 ± 521.92	2244.05 ± 549.78	0.001*	<0.001*	<0.001*	0.325
Birthweight percentile (%)	27.36 ± 20.95	30.14 ± 21.23	36.61 ± 22.46	0.001*	0.319	0.006*	0.002*
Placental weight (g)	958.79 ± 228.46	1029.94 ± 206.78	1107.42 ± 252.54	<0.001*	0.010*	<0.001*	0.001*
SGA, n (%)	13 (19.70%)	93 (19.06%)	17 (12.88%)	0.240	1.000	0.293	0.128
AGA-AGA, n (%)	42 (63.64%)	326 (66.80%)	100 (75.56%)	0.160	0.593	0.193	0.072
AGA-SGA, n (%)	22 (33.33%)	138 (28.28%)	30 (22.73%)
SGA-SGA, n (%)	2 (3.03%)	24 (4.92%)	2 (1.52%)
Twin weight discordance, n (%)	14 (21.21%)	96 (19.67%)	32 (24.24%)	0.513	0.897	0.766	0.303
Apgar score at 1 min (<7), n (%)	23 (34.85%)	116 (23.77%)	34 (25.76%)	0.149	0.072	0.244	0.720
Apgar score at 5 min (<7), n (%)	1 (1.52%)	18 (3.69%)	7 (5.30%)	0.411	0.582	0.372	0.557
NICU admission, (%)	52 (78.79%)	341 (70.16%)	94 (71.21%)	0.636	0.321	0.332	0.847
Oxygen supply	33 (50.00%)	222 (45.68%)	67 (51.15%)	0.478	0.597	0.999	0.311
Intubation	17 (25.76%)	75 (15.53%)	17 (12.98%)	0.060	0.056	0.041*	0.557
RDS	15 (22.73%)	64 (13.17%)	12 (9.16%)	0.030*	0.058	0.017*	0.276

*p value < 0.05. Underweight, BMI < 18.5; normal, 18.5 < BMI < 25; overweight, BMI >25; p-value α, between underweight BMI and normal BMI; p-value β, between underweight BMI and overweight BMI; p-value ɤ, between normal BMI and overweight BMI. SGA, small for gestational age; AGA, adequate for gestational age; NICU, neonatal intensive care unit; RDS

Table 3. Comparisons on obstetrical complications, neonatal prognosis, and maternal weight gain between the AGA-AGA group and AGA-SGA or SGA-SGA group, regardless of BMI using maternal pre-pregnancy weight in twin pregnancy.

	AGA-AGA (n = 234)	AGA-SGA or SGA-SGA (n = 109)	p value
Age (years)	31.67 ± 4.27	33.67 ± 3.97	<0.001*
Nulliparous	153 (65.38%)	83 (76.15%)	0.001*
ART	114 (48.93%)	71 (65.14%)	<0.001*
Monochorionic	54 (23.08%)	24 (22.02%)	0.834
Dichorionic	180 (76.92%)	85 (77.98%)
Preeclampsia	19 (8.12%)	18 (16.51%)	0.002*
Gestational DM	32 (13.68%)	14 (12.84%)	0.859
50 g GTT	131.83 ± 30.88	131.93 ± 29.28	0.976
TSH	2.04 ± 1.59	2.52 ± 2.28	0.007*
Placenta previa	10 (2.14%)	5 (4.59%)	0.074
Threatened preterm labor	162 (69.23%)	45 (41.28%)	<0.001*
PROM	68 (29.06%)	18 (16.51%)	0.001*
Short cervix	126 (53.85%)	28 (29.47%)	<0.001*
Postpartum bleeding	15 (6.41%)	6 (5.50%)	0.772
Cause of delivery Elective Spontaneous Iatrogenic	76 (32.48%) 129 (55.13%) 29 (12.39%)	46 (42.59%) 33 (30.56%) 29 (26.85%)	<0.001*
Gestational age at delivery (weeks)	34.37 ± 2.99	35.81 ± 2.24	<0.001*
Gender, male	244 (47.86%)	107 (49.08%)	0.507
Birthweight (grams)	77.06	2117.34 ± 474.37	0.030*
Birthweight percentile (%)	38.40 ± 19.41	15.47 ± 17.36	<0.001*
Placental weight	1057.80 ± 228.26	995.50 ± 200.74	<0.001*
Twin weight discordance	42 (8.97%)	100 (45.87%)	<0.001*
Apgar score at 1 min (<7)	126 (26.92%)	47 (21.56%)	0.158
Apgar score at 5 min (<7)	17 (3.63%)	9 (4.13%)	0.919
NICU admission	319 (68.45%)	168 (77.06%)	0.025*
Maternal height	161.40 ± 5.10	159.85 ± 4.72	<0.001*
Pre-pregnancy weight	58.52 ± 11.07	55.83 ± 9.41	0.001*
Weight at 15–18 weeks	61.25 ± 10.16	57.86 ± 8.61	<0.001*
Weight at 20–24 weeks	64.13 ± 9.75	61.87 ± 8.96	0.059
Weight at 24–28 weeks	67.50 ± 10.21	64.11 ± 7.95	0.001*
Weight at delivery	72.26 ± 12.30	69.65 ± 9.15	0.002*

*p value < 0.05. AGA, adequate for gestational age; SGA, small for gestational age; ART, artificial reproductive technique; DM, diabetes mellitus; GTT, glucose tolerance test; TSH, PROM, premature rupture of amniotic membrane; NICU, neonatal intensive care unit.

Table 4. Comparisons on maternal weight and weight gain according to gestational age between the AGA-AGA group and AGA-SGA or SGA-SGA group in normal BMI twin pregnancy

	AGA-AGA (n = 162)	AGA-SGA or SGA-SGA (n = 79)	p value
Gestational age at delivery (weeks)	34.40 ± 3.02	35.99 ± 2.28	<0.001*
Birthweight (grams)	2214.83 ± 555.64	2151.27 ± 443.72	0.176
Birthweight percentile (%)	37.88 ± 19.40	14.72 ± 16.57	<0.001*
Height	161.32 ± 5.22	160.14 ± 4.25	0.008*
Pre-pregnancy weight	55.10 ± 5.54	54.51 ± 5.21	0.263
Weight at 15–18 weeks	58.42 ± 6.37	56.19 ± 5.64	0.004*
Weight at 20–24 weeks	62.75 ± 6.91	61.23 ± 5.51	0.091
Weight at 24–28 weeks	65.54 ± 6.93	63.27 ± 5.23	0.003*
Weight at delivery	69.49 ± 8.38	69.12 ± 5.95	0.578
Weight gain during pregnancy (kg)	14.39 ± 5.88	14.61 ± 4.76	0.658
Weight gain during the 1st trimester (kg)	2.89 ± 3.49	2.47 ± 2.90	0.289
Weight gain during the 2nd trimester (kg)	7.21 ± 2.87	6.50 ± 2.04	0.043*
Weight gain during the 3rd trimester (kg)	5.00 ± 3.67	6.27 ± 2.96	0.003*

*p value < 0.05. AGA, adequate for gestational age; SGA, small for gestational age.

Table 5. Comparisons on maternal weight and weight gain according to gestational age between the AGA-AGA group and AGA-SGA or SGA-SGA group in overweight BMI twin pregnancy

	AGA-AGA (n = 49)	AGA-SGA or SGA-SGA (n = 16)	p value
Gestational age at delivery (weeks)	34.54 ± 2.82	35.52 ± 1.97	0.032*
Birthweight (gram)	2269.13 ± 565.92	2140.94 ± 498.56	0.255
Birthweight percentile(%)	41.64 ± 20.16	21.81 ± 23.28	<0.001*
Maternal height, cm	160.97 ± 5.09	158.38 ± 6.25	0.020*
Pre-pregnancy weight, kg	74.42 ± 8.95	70.62 ± 10.90	0.051
Weight at 15–18 weeks	75.84 ± 8.49	70.43 ± 5.79	0.001*
Weight at 20–24 weeks	77.43 ± 9.26	74.83 ± 6.19	0.315
Weight at 24–28 weeks	82.85 ± 9.85	75.61 ± 6.07	0.001*
Weight at delivery	86.42 ± 11.06	80.29 ± 11.77	0.008*
Weight gain during pregnancy, kg	12.01 ± 5.77	9.67 ± 4.02	0.013*
Weight gain during the 1st trimester, kg	2.92 ± 2.99	2.27 ± 2.69	0.354
Weight gain during the 2nd trimester, kg	4.40 ± 2.02	4.57 ± 1.55	0.751
Weight gain during the 3rd trimester, kg	3.73 ± 3.04	3.96 ± 2.09	0.765

*p value < 0.05. AGA, adequate for gestational age; SGA, small for gestational age.

Table 6. Comparisons on maternal weight and weight gain according to gestational age between the AGA-AGA group and AGA-SGA or SGA-SGA group in underweight BMI twin pregnancy

	AGA-AGA (n = 42)	AGA-SGA or SGA-SGA (n = 24)	p value
Gestational age at delivery (weeks)	33.49 ± 3.09	35.11 ± 2.24	0.028*
Birthweight (grams)	1963.21 ± 519.92	1896.67 ± 580.37	0.633
Birthweight percentile (%)	35.83 ± 20.34	12.54 ± 11.94	<0.001*
Maternal height (cm)	162.48 ± 3.82	159.67 ± 5.30	0.015*
Pre-pregnancy weight (kg)	45.81 ± 3.54	44.25 ± 4.72	0.133
Weight at 15–18 weeks	50.17 ± 4.03	46.78 ± 4.35	0.022*
Weight at 20–24 weeks	51.06 ± 3.11	50.00 ± 4.76	0.470
Weight at 24–28 weeks	56.33 ± 4.61	54.30 ± 5.01	0.215
Weight at delivery (kg)	58.59 ± 6.88	57.74 ± 5.88	0.616
Weight gain during the pregnancy (kg)	12.78 ± 5.02	13.49 ± 5.97	0.605
Weight gain during the 1st trimester (kg)	2.99 ± 2.38	3.21 ± 2.76	0.804
Weight gain during the 2nd trimester (kg)	6.57 ± 1.65	6.33 ± 3.45	0.830
Weight gain during the 3rd trimester (kg)	4.49 ± 4.10	3.69 ± 2.89	0.512

*p value < 0.05. AGA, adequate for gestational age; SGA, small for gestational age.

No competing interests reported.

Download PDF

Version 1

posted

You are reading this latest preprint version

Correlation Between Maternal Weight Gain in Each Trimester and Fetal Growth According to Pre-pregnancy Maternal Body Mass Index in Twin Pregnancies

Status:

Version 1

Abstract

Figures

Background

Methods

Statistical Analyses

Results

Discussion

Conclusion

List Of Abbreviations

Declarations

References

Tables

Additional Declarations

Status:

Version 1